Aurobindo Pharma has announced a change in its secretarial audit leadership. Following the resignation of M/s. MRR & Associates due to health reasons of its proprietor, effective May 22, 2026, the Board of Directors has appointed M/s. RPR & Associates as the new Secretarial Auditor. This appointment is for a term of five consecutive years, beginning with the 2026-27 fiscal year, pending approval from shareholders at the upcoming annual general meeting.
Leadership Transition in Secretarial Audit
During a board meeting held on May 21, 2026, Aurobindo Pharma formalized the transition of its secretarial auditing services. The outgoing firm, M/s. MRR & Associates, will step down effective May 22, 2026, citing health-related challenges faced by its sole proprietor.
Appointment of RPR & Associates
The company has appointed M/s. RPR & Associates, a peer-reviewed firm of Company Secretaries in Practice (Registration No: S2017TL469100), to take over the role. The appointment covers a five-year term spanning from FY 2026-27 to FY 2030-31. This transition remains subject to the necessary ratification by shareholders at the company’s next Annual General Meeting.
Firm Expertise
M/s. RPR & Associates brings extensive experience in corporate governance, having served clients for over 23 years under the leadership of proprietor Mr. Y. Ravi Prasada Reddy. The firm specializes in delivering professional services across corporate laws, as well as complex regulatory frameworks, ensuring robust compliance and due diligence for its corporate partners.
Source: BSE
